Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Dean Buckner

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Disorders

Chemicals & Drugs

Phenomena

Recurrence

Concepts & Ideas

Physiology

Graft Survival

Living Beings

Infant

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
111
Appelbaum, Frederick
95
Storb, Rainer
78
Bensinger, William
71
Clift, Reginald
47
Thomas, ED
41
Sanders, Jean
36
Doney, Kristine
32
Weaver, Charles
31
Anasetti, Claudio
25
Fefer, Alexander
23
Lilleby, Kathy
22
Demirer, Taner
22
Witherspoon, Robert
21
Hansen, John
21
Rowley, Scott

Sign-in to see all Coauthors

Publications

TOP 3
Bensinger William I; Buckner C Dean; Lilleby Kathy; Holmberg Leona; Storb Rainer; Slattery John T
Dose escalation of busulfan with pentoxifylline and ciprofloxacin in patients with breast cancer undergoing autologous transplants.
Weaver C H; Buckner C D; Curtis L H; Bajwa K; Weinfurt K P; Wilson-Relyea B J; Schulman K A
Economic evaluation of filgrastim, sargramostim, and sequential sargramostim and filgrastim after myelosuppressive chemotherapy.
Gutierrez-Delgado F; Maloney D G; Press O W; Golden J; Holmberg L A; Maziarz R T; Hooper H; Buckner C D; Appelbaum F R; Bensinger W I
Autologous stem cell transplantation for non-Hodgkin's lymphoma: comparison of radiation-based and chemotherapy-only preparative regimens.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Dean Buckner (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2004: Bensinger William I; Buckner C Dean; Lilleby Kathy; Holmberg Leona; Storb Rainer; Slattery John T
Dose escalation of busulfan with pentoxifylline and ciprofloxacin in patients with breast cancer undergoing autologous transplants.
Oncology 2004;67(5-6):368-75.
2002: Weaver C H; Buckner C D; Curtis L H; Bajwa K; Weinfurt K P; Wilson-Relyea B J; Schulman K A
Economic evaluation of filgrastim, sargramostim, and sequential sargramostim and filgrastim after myelosuppressive chemotherapy.
Bone marrow transplantation 2002;29(2):159-64.
2001: Gutierrez-Delgado F; Maloney D G; Press O W; Golden J; Holmberg L A; Maziarz R T; Hooper H; Buckner C D; Appelbaum F R; Bensinger W I
Autologous stem cell transplantation for non-Hodgkin's lymphoma: comparison of radiation-based and chemotherapy-only preparative regimens.
Bone marrow transplantation 2001;28(5):455-61.
2001: Weaver C H; Schulman K A; Buckner C D
Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim.
Bone marrow transplantation 2001;27 Suppl 2():S23-9.
2001: Buckner C D; Epstein R B; Rudolph R H; Clift R A; Storb R; Thomas E D
Allogeneic marrow engraftment following whole body irradiation in a patient with leukemia. 1970.
Journal of hematotherapy & stem cell research 2001;10(2):201-8.
2000: Weaver C H; Schulman K A; Wilson-Relyea B; Birch R; West W; Buckner C D
Randomized trial of filgrastim, sargramostim, or sequential sargramostim and filgrastim after myelosuppressive chemotherapy for the harvesting of peripheral-blood stem cells.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(1):43-53.
1999: Schwartzberg L; Weaver C; Lewkow L; McAneny B; Zhen B; Birch R; West W; Tauer K; Buckner C
High-dose chemotherapy with peripheral blood stem cell support for stage IIIB inflammatory carcinoma of the breast.
Bone marrow transplantation 1999;24(9):981-7.
1999: Buckner C D
Autologous bone marrow transplants to hematopoietic stem cell support with peripheral blood stem cells: a historical perspective.
Journal of hematotherapy 1999;8(3):233-6.
1999: Demirer T; Bensinger W I; Buckner C D
Peripheral blood stem cell mobilization for high-dose chemotherapy.
Journal of hematotherapy 1999;8(2):103-13.
1999: Schwartzberg L S; Weaver C H; Birch R; Giudice R; Sobong E; Schnell F; Kalman L; Buckner C D
Single-agent paclitaxel in patients with metastatic breast cancer receiving high-dose chemotherapy with peripheral blood stem cell support.
American journal of clinical oncology 1999;22(2):162-7.
1999: Schwartzberg L S; Birch R; Tauer K W; Leff R; Greco F A; Hainsworth J; Raefsky E; McAneny B; Weaver Z; West J; Buckner C D; Weaver C H
Adjuvant dose-intense chemotherapy with peripheral blood stem cell support in stage II-III breast cancer with five to nine involved axillary lymph nodes.
American journal of clinical oncology 1999;22(2):136-42.
1999: Weaver C H; Schwartzberg L S; Zhen B; Franco C; Moore M; Smith R; White L; Van Amburg A; Hazelton B; Buckner C D
Mobilization of peripheral blood stem cells with docetaxel and cyclophosphamide (CY) in patients with metastatic breast cancer: a randomized trial of 3 vs 4 g/m2 of CY.
Bone marrow transplantation 1999;23(5):421-5.
1998: Birch R; Weaver C H; Carson K; Buckner C D
A randomized trial of once vs twice daily administration of intravenous granisetron with dexamethosone in patients receiving high-dose cyclophosphamide, thiotepa and carboplatin.
Bone marrow transplantation 1998;22(7):685-8.
1998: Holmberg L A; Demirer T; Rowley S; Buckner C D; Goodman G; Maziarz R; Klarnet J; Zuckerman N; Harrer G; McCloskey R; Gersh R; Goldberg R; Nichols W; Jacobs A; Weiden P; Montgomery P; Rivkin S; Appelbaum F R; Bensinger W I
High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell (PBSC) rescue in patients with advanced stage III/IV ovarian cancer.
Bone marrow transplantation 1998;22(7):651-9.
1998: Schwartzberg L S; Birch R; West W H; Tauer K W; Wittlin F; Leff R; Campos L; Rymer W; Carter P; Mangum M; Greco F A; Hainsworth J; Raefsky E; Blanco R; Buckner C D; Weaver C H
Sequential treatment including high-dose chemotherapy with peripheral blood stem cell support in patients with high-risk stage II-III breast cancer: outpatient administration in community cancer centers.
American journal of clinical oncology 1998;21(5):523-31.
1998: Weaver C H; Zhen B; Schwartzberg L S; Leff R; Magee M; Geier L; Deaton K; Lewkow L; Buckner C D
Phase I-II evaluation of rapid sequence tandem high-dose melphalan with peripheral blood stem cell support in patients with multiple myeloma.
Bone marrow transplantation 1998;22(3):245-51.
1998: Weaver C H; Zhen B; Schwartzberg L; Walker C; Upton S; Buckner C D
A randomized trial of mobilization of peripheral blood stem cells with cyclophosphamide, etoposide, and granulocyte colony-stimulating factor with or without cisplatin in patients with malignant lymphoma receiving high-dose chemotherapy.
American journal of clinical oncology 1998;21(4):408-12.
1998: Clift R A; Buckner C D; Appelbaum F R; Sullivan K M; Storb R; Thomas E D
Long-term follow-Up of a randomized trial of two irradiation regimens for patients receiving allogeneic marrow transplants during first remission of acute myeloid leukemia.
Blood 1998;92(4):1455-6.
1998: Weaver C H; Zhen B; Buckner C D
Treatment of patients with malignant lymphoma with Mini-BEAM reduces the yield of CD34+ peripheral blood stem cells.
Bone marrow transplantation 1998;21(11):1169-70.
1998: Weaver C H; Moss T; Schwartzberg L S; Zhen B; West J; Rhinehart S; Campos L; Beeker T; Lautersztain L; Messino M; Buckner C D
High-dose chemotherapy in patients with breast cancer: evaluation of infusing peripheral blood stem cells containing occult tumor cells.
Bone marrow transplantation 1998;21(11):1117-24.
1998: Weaver C H; Tauer K; Zhen B; Schwartzberg L S; Hazelton B; Weaver Z; Lewkow L; Allen C; Longin K; Buckner C D
Second attempts at mobilization of peripheral blood stem cells in patients with initial low CD34+ cell yields.
Journal of hematotherapy 1998;7(3):241-9.
1998: Schwartzberg L S; Weaver C H; Birch R; Manner C; Tauer K; Beeker T; Morgan-Ihrig C; MacAneny B; Leff R; Smith R; Hainsworth J; Greco T; Schwerkoske J; Murphy M N; Buckner C D
A randomized trial of two doses of cyclophosphamide with etoposide and G-CSF for mobilization of peripheral blood stem cells in 318 patients with stage II-III breast cancer.
Journal of hematotherapy 1998;7(2):141-50.
1998: Weaver C H; Schwartzberg L; Rhinehart S; West J; Zhen B; West W H; Buckner C D
High-dose chemotherapy with BUCY or BEAC and unpurged peripheral blood stem cell infusion in patients with low-grade non-Hodgkin's lymphoma.
Bone marrow transplantation 1998;21(4):383-9.
1998: Weaver C H; Birch R; Greco F A; Schwartzberg L; McAneny B; Moore M; Oviatt D; Redmond J; George C; Alberico T; Johnson P; Buckner C D
Mobilization and harvesting of peripheral blood stem cells: randomized evaluations of different doses of filgrastim.
British journal of haematology 1998;100(2):338-47.
1998: Sullivan K M; Kansu E; Storer B; Jocom J; Emerson G; Reagan T; Emerson V; Siadak M F; Davis C; Appelbaum F R; Buckner C D; Hansen J A; Shulman H M; Storb R; McDonald G B
Intravenous immunoglobulin and the risk of hepatic veno-occlusive disease after bone marrow transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1998;4(1):20-6.
1998: Williams O; Demirer T; Lilleby K; Buckner C D; Bensinger W I
Tempo of hematologic recovery correlates with peripheral blood CD34+ cell level in patients undergoing stem cell mobilization.
Journal of clinical apheresis 1998;13(1):1-6.
1998: Clift R A; Buckner C D
Marrow transplantation for acute myeloid leukemia.
Cancer investigation 1998;16(1):53-61.
1997: Schiffman K; Buckner C D; Maziarz R; Maloney D G; Appelbaum F R; Press O; Gooley T; Holmberg L; Lilleby K; Clift R; Zuckerman N; Klarnet J; Weaver C; Chauncey T; Bensinger W I
High-dose busulfan, melphalan, and thiotepa followed by autologous peripheral blood stem cell transplantation in patients with aggressive lymphoma or relapsed Hodgkin's disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(5):261-6.
1997: Weaver C H; Greco F A; Hainsworth J D; Zhen B; Baldwin P; Wittlin F; Lewis M; West W H; Schwartzberg L; Buckner C D
A phase I-II study of high-dose melphalan, mitoxantrone and carboplatin with peripheral blood stem cell support in patients with advanced ovarian or breast carcinoma.
Bone marrow transplantation 1997;20(10):847-53.
1997: Weaver C H; Schwartzberg L; Zhen B; Mangum M; Leff R; Tauer K; Rosenberg A; Pendergrass K; Kaywin P; Hainsworth J; Greco F A; West W H; Buckner C D
High-dose chemotherapy and peripheral blood stem cell infusion in patients with non-Hodgkin's lymphoma: results of outpatient treatment in community cancer centers.
Bone marrow transplantation 1997;20(9):753-60.
1997: Storb R; Leisenring W; Anasetti C; Appelbaum F R; Deeg H J; Doney K; Martin P; Sullivan K M; Witherspoon R; Pettinger M; Bensinger W; Buckner C D; Clift R; Flowers M E; Hansen J A; Pepe M; Chauncey T; Sanders J; Thomas E D
Methotrexate and cyclosporine for graft-vs.-host disease prevention: what length of therapy with cyclosporine?
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(4):194-201.
1997: Weaver C H; Schwartzberg L S; Birch R; Greco F A; Rhinehart S; Hainsworth J; Beeker T; Price H; Geier L; Foster J; West J; Hazelton B; Buckner C D
Collection of peripheral blood progenitor cells after the administration of cyclophosphamide, etoposide, and granulocyte-colony-stimulating factor: an analysis of 497 patients.
Transfusion 1997;37(9):896-903.
1997: Weaver C H; Schwartzberg L S; Birch R; Greco F A; Hainsworth J; Drapkin R; Campos L; Grapski R; Schwerkoske J; Lautersztain J; Hazelton B; Schnell F; Babcock W; Buckner C D
Collection of peripheral blood stem cells following administration of paclitaxel, cyclophosphamide, and filgrastim in patients with breast and ovarian cancer.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(2):83-90.
1997: Bensinger W I; Schiffman K S; Holmberg L; Appelbaum F R; Maziarz R; Montgomery P; Ellis E; Rivkin S; Weiden P; Lilleby K; Rowley S; Petersdorf S; Klarnet J P; Nichols W; Hertler A; McCroskey R; Weaver C H; Buckner C D
High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancer.
Bone marrow transplantation 1997;19(12):1183-9.
1997: Weaver C H; Potz J; Redmond J; Tauer K; Schwartzberg L S; Kaywin P; Drapkin R; Grant B; Unger P; Allen C; Longin K; Zhen B; Hazelton B; Buckner C D
Engraftment and outcomes of patients receiving myeloablative therapy followed by autologous peripheral blood stem cells with a low CD34+ cell content.
Bone marrow transplantation 1997;19(11):1103-10.
1997: Storb R; Leisenring W; Anasetti C; Appelbaum F R; Buckner C D; Bensinger W I; Chauncey T; Clift R A; Deeg H J; Doney K C; Flowers M E; Hansen J A; Martin P J; Sanders J E; Sullivan K M; Witherspoon R P
Long-term follow-up of allogeneic marrow transplants in patients with aplastic anemia conditioned by cyclophosphamide combined with antithymocyte globulin.
Blood 1997;89(10):3890-1.
1997: Weaver C H; Schwartzberg L S; Hainsworth J; Greco F A; Li W; Buckner C D; West W H
Treatment-related mortality in 1000 consecutive patients receiving high-dose chemotherapy and peripheral blood progenitor cell transplantation in community cancer centers.
Bone marrow transplantation 1997;19(7):671-8.
1997: Weaver C H; West W H; Schwartzberg L S; Alberico T; Leff R; Greco F A; Hainsworth J; Birch R; McAneny B; Magee M; Raefsky E; Kalman L; Buckner C D
Induction, mobilization of peripheral blood stem cells (PBSC), high-dose chemotherapy and PBSC infusion in patients with untreated stage IV breast cancer: outcomes by intent to treat analyses.
Bone marrow transplantation 1997;19(7):661-70.
1997: Slattery J T; Clift R A; Buckner C D; Radich J; Storer B; Bensinger W I; Soll E; Anasetti C; Bowden R; Bryant E; Chauncey T; Deeg H J; Doney K C; Flowers M; Gooley T; Hansen J A; Martin P J; McDonald G B; Nash R; Petersdorf E W; Sanders J E; Schoch G; Stewart P; Storb R; Sullivan K M; Thomas E D; Witherspoon R P; Appelbaum F R
Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation.
Blood 1997;89(8):3055-60.
1997: Buckner C D; Bensinger W I
Allogeneic peripheral blood stem cell transplantation.
[Rinsho ketsueki] The Japanese journal of clinical hematology 1997;38(3):157-61.
1997: Robinson N; Benyunes M C; Thompson J A; York A; Petersdorf S; Press O; Lindgren C; Chauncey T; Buckner C D; Bensinger W I; Appelbaum F R; Fefer A
Interleukin-2 after autologous stem cell transplantation for hematologic malignancy: a phase I/II study.
Bone marrow transplantation 1997;19(5):435-42.
1997: Demirer T; Buckner C D; Storer B; Lilleby K; Rowley S; Clift R; Appelbaum F R; Storb R; Bensinger W I
Effect of different chemotherapy regimens on peripheral-blood stem-cell collections in patients with breast cancer receiving granulocyte colony-stimulating factor.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):684-90.
1996: Bensinger W I; Buckner C D; Shannon-Dorcy K; Rowley S; Appelbaum F R; Benyunes M; Clift R; Martin P; Demirer T; Storb R; Lee M; Schiller G
Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy.
Blood 1996;88(11):4132-8.
1996: Huss R; Deeg H J; Gooley T; Bryant E; Leisenring W; Clift R; Buckner C D; Martin P; Storb R; Appelbaum F R
Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia.
Bone marrow transplantation 1996;18(4):767-76.
1996: Bensinger W I; Clift R; Martin P; Appelbaum F R; Demirer T; Gooley T; Lilleby K; Rowley S; Sanders J; Storb R; Buckner C D
Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation.
Blood 1996;88(7):2794-800.
1996: Bensinger W I; Buckner C D; Anasetti C; Clift R; Storb R; Barnett T; Chauncey T; Shulman H; Appelbaum F R
Allogeneic marrow transplantation for multiple myeloma: an analysis of risk factors on outcome.
Blood 1996;88(7):2787-93.
1996: Bensinger W I; Demirer T; Buckner C D; Appelbaum F R; Storb R; Lilleby K; Weiden P; Bluming A Z; Fefer A
Syngeneic marrow transplantation in patients with multiple myeloma.
Bone marrow transplantation 1996;18(3):527-31.
1996: Brunvand M W; Bensinger W I; Soll E; Weaver C H; Rowley S D; Appelbaum F R; Lilleby K; Clift R A; Gooley T A; Press O W; Fefer A; Storb R; Sanders J E; Martin P L; Chauncey T; Maziarz R T; Zuckerman N; Montgomery P; Dorn R; Weiden P L; Demirer T; Holmberg L A; Schiffman K; McSweeney P A; Buckner C D
High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: comparison of autologous bone marrow and peripheral blood stem cells.
Bone marrow transplantation 1996;18(1):131-41.
1996: McSweeney P A; Wells D A; Shults K E; Nash R A; Bensinger W I; Buckner C D; Loken M R
Tumor-specific aneuploidy not detected in CD19+ B-lymphoid cells from myeloma patients in a multidimensional flow cytometric analysis.
Blood 1996;88(2):622-32.
1996: Schiffman K S; Bensinger W I; Appelbaum F R; Rowley S; Lilleby K; Clift R A; Weaver C H; Demirer T; Sanders J E; Petersdorf S; Gooley T; Weiden P; Zuckerman N; Montgomery P; Maziarz R; Klarnet J P; Rivkin S; Trueblood K; Storb R; Holmberg L; Buckner C D
Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant disease.
Bone marrow transplantation 1996;17(6):943-50.
1996: Demirer T; Buckner C D; Gooley T; Appelbaum F R; Rowley S; Chauncey T; Lilleby K; Storb R; Bensinger W I
Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma.
Bone marrow transplantation 1996;17(6):937-41.
1996: Demirer T; Buckner C D; Appelbaum F R; Clift R; Storb R; Myerson D; Lilleby K; Rowley S; Bensinger W I
High-dose busulfan and cyclophosphamide followed by autologous transplantation in patients with advanced breast cancer.
Bone marrow transplantation 1996;17(5):769-74.
1996: Attarian H; Bensinger W I; Buckner C D; McDonald D L; Rowley S D
Microbial contamination of peripheral blood stem cell collections.
Bone marrow transplantation 1996;17(5):699-702.
1996: Slattery J T; Kalhorn T F; McDonald G B; Lambert K; Buckner C D; Bensinger W I; Anasetti C; Appelbaum F R
Conditioning regimen-dependent disposition of cyclophosphamide and hydroxycyclophosphamide in human marrow transplantation patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(5):1484-94.
1996: Bensinger W I; Rowley S D; Demirer T; Lilleby K; Schiffman K; Clift R A; Appelbaum F R; Fefer A; Barnett T; Storb R; Chauncey T; Maziarz R T; Klarnet J; McSweeney P; Holmberg L; Maloney D G; Weaver C H; Buckner C D
High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(5):1447-56.
1996: Demirer T; Buckner C D; Appelbaum F R; Bensinger W I; Sanders J; Lambert K; Clift R; Fefer A; Storb R; Slattery J T
Busulfan, cyclophosphamide and fractionated total body irradiation for autologous or syngeneic marrow transplantation for acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levels.
Bone marrow transplantation 1996;17(4):491-5.
1996: Sanders J E; Hawley J; Levy W; Gooley T; Buckner C D; Deeg H J; Doney K; Storb R; Sullivan K; Witherspoon R; Appelbaum F R
Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation.
Blood 1996;87(7):3045-52.
1996: Anderson J E; Anasetti C; Appelbaum F R; Schoch G; Gooley T A; Hansen J A; Buckner C D; Sanders J E; Sullivan K M; Storb R
Unrelated donor marrow transplantation for myelodysplasia (MDS) and MDS-related acute myeloid leukaemia.
British journal of haematology 1996;93(1):59-67.
1996: Bensinger W I; Buckner C D; Demirer T; Storb R; Appelbaum F A
Transplantation of allogeneic peripheral blood stem cells.
Bone marrow transplantation 1996;17 Suppl 2():S56-7.
1996: Bensinger W I; Buckner C D; Rowley S; Demirer T; Storb R; Appelbaum F A
Transplantation of allogeneic CD34+ peripheral blood stem cells (PBSC) in patients with advanced hematologic malignancy.
Bone marrow transplantation 1996;17 Suppl 2():S38-9.
1996: Bensinger W I; Buckner C D; Rowley S; Storb R; Appelbaum F R
Treatment of normal donors with recombinant growth factors for transplantation of allogeneic blood stem cells.
Bone marrow transplantation 1996;17 Suppl 2():S19-21.
1996: Attarian H; Feng Z; Buckner C D; MacLeod B; Rowley S D
Long-term cryopreservation of bone marrow for autologous transplantation.
Bone marrow transplantation 1996;17(3):425-30.
1996: Massumoto C; Benyunes M C; Sale G; Beauchamp M; York A; Thompson J A; Buckner C D; Fefer A
Close simulation of acute graft-versus-host disease by interleukin-2 administered after autologous bone marrow transplantation for hematologic malignancy.
Bone marrow transplantation 1996;17(3):351-6.
1996: Demirer T; Buckner C D; Appelbaum F R; Lambert K; Bensinger W I; Clift R; Storb R; Slattery J T
Busulfan, cyclophosphamide and fractionated total body irradiation for allogeneic marrow transplantation in advanced acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levels.
Bone marrow transplantation 1996;17(3):341-6.
1996: Sullivan K M; Storek J; Kopecky K J; Jocom J; Longton G; Flowers M; Siadak M; Nims J; Witherspoon R P; Anasetti C; Appelbaum F R; Bowden R A; Buckner C D; Crawford S W; Deeg H J; Hansen J A; McDonald G B; Sanders J E; Storb R
A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: clinical outcome and effect on subsequent immune recovery.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1996;2(1):44-53.
1996: Anderson J E; Appelbaum F R; Schoch G; Gooley T; Anasetti C; Bensinger W I; Bryant E; Buckner C D; Chauncey T; Clift R A
Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic factors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(1):220-6.
1996: Anderson J E; Appelbaum F R; Schoch G; Gooley T; Anasetti C; Bensinger W I; Bryant E; Buckner C D; Chauncey T R; Clift R A; Doney K; Flowers M; Hansen J A; Martin P J; Matthews D C; Sanders J E; Shulman H; Sullivan K M; Witherspoon R P; Storb R
Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimens and analysis of prognostic factors.
Blood 1996;87(1):51-8.
1995: Soll E; Massumoto C; Clift R A; Buckner C D; Appelbaum F R; Storb R; Sale G; Hackman R; Martin P
Relevance of marrow fibrosis in bone marrow transplantation: a retrospective analysis of engraftment.
Blood 1995;86(12):4667-73.
1995: Balduzzi A; Gooley T; Anasetti C; Sanders J E; Martin P J; Petersdorf E W; Appelbaum F R; Buckner C D; Matthews D; Storb R; Sullivan K M; Hansen J A
Unrelated donor marrow transplantation in children.
Blood 1995;86(8):3247-56.
1995: Boeckh M; Gooley T A; Reusser P; Buckner C D; Bowden R A
Failure of high-dose acyclovir to prevent cytomegalovirus disease after autologous marrow transplantation.
The Journal of infectious diseases 1995;172(4):939-43.
1995: Kalhs P; Schwarzinger I; Anderson G; Mori M; Clift R A; Storb R; Buckner C D; Appelbaum F R; Hansen J A; Sullivan K M
A retrospective analysis of the long-term effect of splenectomy on late infections, graft-versus-host disease, relapse, and survival after allogeneic marrow transplantation for chronic myelogenous leukemia.
Blood 1995;86(5):2028-32.
1995: Appelbaum F R; Clift R; Radich J; Anasetti C; Buckner C D
Bone marrow transplantation for chronic myelogenous leukemia.
Seminars in oncology 1995;22(4):405-11.
1995: Benyunes M C; Higuchi C; York A; Lindgren C; Thompson J A; Buckner C D; Fefer A
Immunotherapy with interleukin 2 with or without lymphokine-activated killer cells after autologous bone marrow transplantation for malignant lymphoma: a feasibility trial.
Bone marrow transplantation 1995;16(2):283-8.
1995: Slattery J T; Sanders J E; Buckner C D; Schaffer R L; Lambert K W; Langer F P; Anasetti C; Bensinger W I; Fisher L D; Appelbaum F R
Graft-rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics.
Bone marrow transplantation 1995;16(1):31-42.
1995: Demirer T; Rowley S; Buckner C D; Appelbaum F R; Lilleby K; Storb R; Schiffman K; Bensinger W I
Peripheral-blood stem-cell collections after paclitaxel, cyclophosphamide, and recombinant human granulocyte colony-stimulating factor in patients with breast and ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(7):1714-9.
1995: Demirer T; Buckner C D; Appelbaum F R; Petersen F B; Rowley S; Weaver C H; Lilleby K; Sanders J; Chauncey T; Storb R
Rapid engraftment after autologous transplantation utilizing marrow and recombinant granulocyte colony-stimulating factor-mobilized peripheral blood stem cells in patients with acute myelogenous leukemia.
Bone marrow transplantation 1995;15(6):915-22.
1995: Demirer T; Gooley T; Buckner C D; Petersen F B; Lilleby K; Rowley S; Sanders J; Storb R; Appelbaum F R; Bensinger W I
Influence of total nucleated cell dose from marrow harvests on outcome in patients with acute myelogenous leukemia undergoing autologous transplantation.
Bone marrow transplantation 1995;15(6):907-13.
1995: Demirer T; Weaver C H; Buckner C D; Petersen F B; Bensinger W I; Sanders J; Clift R A; Lilleby K; Anasetti C; Martin P
High-dose cyclophosphamide, carmustine, and etoposide followed by allogeneic bone marrow transplantation in patients with lymphoid malignancies who had received prior dose-limiting radiation therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(3):596-602.
1995: Bensinger W I; Weaver C H; Appelbaum F R; Rowley S; Demirer T; Sanders J; Storb R; Buckner C D
Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor.
Blood 1995;85(6):1655-8.
1995: Langenmayer I; Weaver C; Buckner C D; Lilleby K; Appelbaum F R; Longin K; Rowley S; Storb R; Singer J; Bensinger W I
Engraftment of patients with lymphoid malignancies transplanted with autologous bone marrow, peripheral blood stem cells or both.
Bone marrow transplantation 1995;15(2):241-6.
1995: Lynch M H; Petersen F B; Appelbaum F R; Bensinger W I; Clift R A; Storb R; Sanders J E; Hansen J A; Buckner C D
Phase II study of busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for allogeneic bone marrow transplantation in patients with advanced myeloid malignancies.
Bone marrow transplantation 1995;15(1):59-64.
1994: Clift R A; Buckner C D; Thomas E D; Bryant E; Anasetti C; Bensinger W I; Bowden R; Deeg H J; Doney K C; Fisher L D
Marrow transplantation for patients in accelerated phase of chronic myeloid leukemia.
Blood 1994;84(12):4368-73.
1994: Nemunaitis J; Ross M; Meisenberg B; O'Reilly R; Lilleby K; Buckner C D; Appelbaum F R; Buhles W; Singer J; Peters W P
Phase I study of recombinant human interleukin-1 beta (rhIL-1 beta) in patients with bone marrow failure.
Bone marrow transplantation 1994;14(4):583-8.
1994: Clift R A; Buckner C D; Thomas E D; Bensinger W I; Bowden R; Bryant E; Deeg H J; Doney K C; Fisher L D; Hansen J A
Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide.
Blood 1994;84(6):2036-43.
1994: Storb R; Etzioni R; Anasetti C; Appelbaum F R; Buckner C D; Bensinger W; Bryant E; Clift R; Deeg H J; Doney K
Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia.
Blood 1994;84(3):941-9.
1994: Demirer T; Buckner C D; Lilleby K; Weaver C; Longin K; Appelbaum F R; Bensinger W I
Failure of a single cycle of high dose cyclophosphamide followed by intensive myeloablative therapy and autologous stem cell transplantation to improve outcome in relapsed disease.
Cancer 1994;74(2):715-21.
1994: Nemunaitis J; Appelbaum F R; Lilleby K; Buhles W C; Rosenfeld C; Zeigler Z R; Shadduck R K; Singer J W; Meyer W; Buckner C D
Phase I study of recombinant interleukin-1 beta in patients undergoing autologous bone marrow transplant for acute myelogenous leukemia.
Blood 1994;83(12):3473-9.
1994: Busca A; Anasetti C; Anderson G; Appelbaum F R; Buckner C D; Doney K; Martin P J; Petersdorf E; Sanders J E; Hansen J A
Unrelated donor or autologous marrow transplantation for treatment of acute leukemia.
Blood 1994;83(10):3077-84.
1994: Rowley S D; Bensinger W I; Gooley T A; Buckner C D
Effect of cell concentration on bone marrow and peripheral blood stem cell cryopreservation.
Blood 1994;83(9):2731-6.
1994: Weaver C H; Longin K; Buckner C D; Bensinger W
Lymphocyte content in peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor.
Bone marrow transplantation 1994;13(4):411-5.
1994: Neubauer M A; Benyunes M C; Thompson J A; Bensinger W I; Lindgren C G; Buckner C D; Fefer A
Lymphokine-activated killer (LAK) precursor cell activity is present in infused peripheral blood stem cells and in the blood after autologous peripheral blood stem cell transplantation.
Bone marrow transplantation 1994;13(3):311-6.
1994: Bearman S I; Mori M; Beatty P G; Meyer W G; Buckner C D; Petersen F B; Sanders J E; Anasetti C; Martin P; Appelbaum F R
Comparison of morbidity and mortality after marrow transplantation from HLA-genotypically identical siblings and HLA-phenotypically identical unrelated donors.
Bone marrow transplantation 1994;13(1):31-5.
1994: Benyunes M C; Thompson J A; York A; Buckner C D; Fefer A
Immunotherapy with interleukin-2 after autologous bone marrow transplantation for hematologic malignancies.
Progress in clinical and biological research 1994;389():229-38.
1993: Fefer A; Benyunes M C; Massumoto C; Higuchi C; York A; Buckner C D; Thompson J A
Interleukin-2 therapy after autologous bone marrow transplantation for hematologic malignancies.
Seminars in oncology 1993;20(6 Suppl 9):41-5.
1993: Anderson J E; Litzow M R; Appelbaum F R; Schoch G; Fisher L D; Buckner C D; Petersen F B; Crawford S W; Press O W; Sanders J E
Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experience.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(12):2342-50.
1993: Clift R A; Bianco J A; Appelbaum F R; Buckner C D; Singer J W; Bakke L; Bensinger W I; Bowden R A; McDonald G B; Schubert M
A randomized controlled trial of pentoxifylline for the prevention of regimen-related toxicities in patients undergoing allogeneic marrow transplantation.
Blood 1993;82(7):2025-30.
1993: Doney K; Buckner C D; Fisher L; Petersen F B; Sanders J; Appelbaum F R; Anasetti C; Badger C; Bensinger W; Deeg H J
Autologous bone marrow transplantation for acute lymphoblastic leukemia.
Bone marrow transplantation 1993;12(4):315-21.
1993: Weaver C H; Buckner C D; Longin K; Appelbaum F R; Rowley S; Lilleby K; Miser J; Storb R; Hansen J A; Bensinger W
Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor.
Blood 1993;82(7):1981-4.
1993: Pavletic Z; Benyunes M C; Thompson J A; Lindgren C G; Massumoto C; Alderson M R; Buckner C D; Fefer A
Induction by interleukin-7 of lymphokine-activated killer activity in lymphocytes from autologous and syngeneic marrow transplant recipients before and after systemic interleukin-2 therapy.
Experimental hematology 1993;21(10):1371-8.
1993: Doney K; Storb R; Appelbaum F R; Buckner C D; Sanders J; Singer J; Hansen J A
Recombinant granulocyte-macrophage colony stimulating factor followed by immunosuppressive therapy for aplastic anaemia.
British journal of haematology 1993;85(1):182-4.
1993: Benyunes M C; Massumoto C; York A; Higuchi C M; Buckner C D; Thompson J A; Petersen F B; Fefer A
Interleukin-2 with or without lymphokine-activated killer cells as consolidative immunotherapy after autologous bone marrow transplantation for acute myelogenous leukemia.
Bone marrow transplantation 1993;12(2):159-63.
1993: Anderson J E; Appelbaum F R; Fisher L D; Schoch G; Shulman H; Anasetti C; Bensinger W I; Bryant E; Buckner C D; Doney K
Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome.
Blood 1993;82(2):677-81.
1993: Bensinger W I; Price T H; Dale D C; Appelbaum F R; Clift R; Lilleby K; Williams B; Storb R; Thomas E D; Buckner C D
The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis.
Blood 1993;81(7):1883-8.
1993: Pene R; Appelbaum F R; Fisher L; Lilleby K; Nemunaitis J; Storb R; Buckner C D
Use of granulocyte-macrophage colony-stimulating factor and erythropoietin in combination after autologous marrow transplantation.
Bone marrow transplantation 1993;11(3):219-22.
1993: Nemunaitis J; Anasetti C; Buckner C D; Appelbaum F R; Shannon-Dorcy K; Hansen J; Singer J W
Long-term follow-up of 103 patients who received recombinant human granulocyte-macrophage colony-stimulating factor after unrelated donor bone marrow transplantation.
Blood 1993;81(3):865.
1993: Radich J P; Sanders J E; Buckner C D; Martin P J; Petersen F B; Bensinger W; McDonald G B; Mori M; Schoch G; Hansen J A
Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(2):304-13.
1993: Fefer A; Benyunes M; Higuchi C; York A; Massumoto C; Lindgren C; Buckner C D; Thompson J A
Interleukin-2 +/- lymphocytes as consolidative immunotherapy after autologous bone marrow transplantation for hematologic malignancies.
Acta haematologica 1993;89 Suppl 1():2-7.
1992: York A; Clift R A; Sanders J E; Buckner C D
Recombinant human erythropoietin (rh-Epo) administration to normal marrow donors.
Bone marrow transplantation 1992;10(5):415-7.
1992: de Oliveira J S; Sale G E; Bryant E M; Sanders J; Buckner C D
Acute megakaryoblastic leukemia in children: treatment with bone marrow transplantation.
Bone marrow transplantation 1992;10(5):399-403.
1992: Clift R A; Buckner C D; Appelbaum F R; Schoch G; Petersen F B; Bensinger W I; Sanders J; Sullivan K M; Storb R; Singer J
Allogeneic marrow transplantation during untreated first relapse of acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(11):1723-9.
1992: Bensinger W I; Buckner C D; Clift R A; Petersen F B; Bianco J A; Singer J W; Appelbaum F R; Dalton W; Beatty P; Fefer A
Phase I study of busulfan and cyclophosphamide in preparation for allogeneic marrow transplant for patients with multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(9):1492-7.
1992: Petersen F B; Buckner C D; Appelbaum F R; Sanders J E; Bensinger W I; Storb R; Deeg H J; Witherspoon R P; Sullivan K M; Clift R A
Etoposide, cyclophosphamide and fractionated total body irradiation as a preparative regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study.
Bone marrow transplantation 1992;10(1):83-8.
1992: Doney K; Pepe M; Storb R; Bryant E; Anasetti C; Appelbaum F R; Buckner C D; Sanders J; Singer J; Sullivan K
Immunosuppressive therapy of aplastic anemia: results of a prospective, randomized trial of antithymocyte globulin (ATG), methylprednisolone, and oxymetholone to ATG, very high-dose methylprednisolone, and oxymetholone.
Blood 1992;79(10):2566-71.
1992: Flowers M E; Doney K C; Storb R; Deeg H J; Sanders J E; Sullivan K M; Bryant E; Witherspoon R P; Appelbaum F R; Buckner C D
Marrow transplantation for Fanconi anemia with or without leukemic transformation: an update of the Seattle experience.
Bone marrow transplantation 1992;9(3):167-73.
1992: Petersen F B; Deeg H J; Buckner C D; Appelbaum F R; Storb R; Clift R A; Sanders J E; Bensinger W I; Witherspoon R P; Sullivan K M
Marrow transplantation following escalating doses of fractionated total body irradiation and cyclophosphamide--a phase I trial.
International journal of radiation oncology, biology, physics 1992;23(5):1027-32.
1992: Buckner C D; Doney K; Sanders J; Petersen F; Appelbaum F
Marrow transplantation for patients with acute lymphoblastic leukemia: the Seattle experience.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1992;6 Suppl 2():193-5.
1992: Clift R; Buckner C D; Bianco J; Petersen F; Appelbaum F
Marrow transplantation in patients with acute myeloid leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1992;6 Suppl 2():104-9.
1992: Appelbaum F R; Badger C C; Bernstein I D; Buckner C D; Deeg H J; Eary J F; Matthews D C; Press O W; Storb R; Thomas E D
Is there a better way to deliver total body irradiation?
Bone marrow transplantation 1992;10 Suppl 1():77-81.
1992: Sullivan K M; Mori M; Sanders J; Siadak M; Witherspoon R P; Anasetti C; Appelbaum F R; Bensinger W; Bowden R; Buckner C D
Late complications of allogeneic and autologous marrow transplantation.
Bone marrow transplantation 1992;10 Suppl 1():127-34.
1991: Van der Jagt R H; Appelbaum F R; Petersen F B; Bigelow C L; Fisher L D; Schoch G H; Buckner C D; Sanders J E; Storb R; Sullivan K M
Busulfan and cyclophosphamide as a preparative regimen for bone marrow transplantation in patients with prior chest radiotherapy.
Bone marrow transplantation 1991;8(3):211-5.
1991: Nemunaitis J; Meyers J D; Buckner C D; Shannon-Dorcy K; Mori M; Shulman H; Bianco J A; Higano C S; Groves E; Storb R
Phase I trial of recombinant human macrophage colony-stimulating factor in patients with invasive fungal infections.
Blood 1991;78(4):907-13.
1991: Storb R; Anasetti C; Appelbaum F; Bensinger W; Buckner C D; Clift R; Deeg H J; Doney K; Hansen J; Loughran T
Marrow transplantation for severe aplastic anemia and thalassemia major.
Seminars in hematology 1991;28(3):235-9.
1991: Buckner C D; Clift R A; Appelbaum F R; Storb R; Fefer A; Petersen F B; Sanders J E; Sullivan K; Thomas E D; Hansen J A
Effects of treatment regimens on post marrow transplant relapse.
Seminars in hematology 1991;28(3 Suppl 4):32-4.
1991: Higuchi C M; Thompson J A; Petersen F B; Buckner C D; Fefer A
Toxicity and immunomodulatory effects of interleukin-2 after autologous bone marrow transplantation for hematologic malignancies.
Blood 1991;77(12):2561-8.
1991: Doney K; Fisher L D; Appelbaum F R; Buckner C D; Storb R; Singer J; Fefer A; Anasetti C; Beatty P; Bensinger W
Treatment of adult acute lymphoblastic leukemia with allogeneic bone marrow transplantation. Multivariate analysis of factors affecting acute graft-versus-host disease, relapse, and relapse-free survival.
Bone marrow transplantation 1991;7(6):453-9.
1991: Nemunaitis J; Buckner C D; Appelbaum F R; Higano C S; Mori M; Bianco J; Epstein C; Lipani J; Hansen J; Storb R
Phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor following allogeneic bone marrow transplantation.
Blood 1991;77(9):2065-71.
1991: Clift R A; Buckner C D; Appelbaum F R; Bryant E; Bearman S I; Petersen F B; Fisher L D; Anasetti C; Beatty P; Bensinger W I
Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: a randomized trial of two irradiation regimens.
Blood 1991;77(8):1660-5.
1991: Berenson R J; Bensinger W I; Hill R S; Andrews R G; Garcia-Lopez J; Kalamasz D F; Still B J; Spitzer G; Buckner C D; Bernstein I D
Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma.
Blood 1991;77(8):1717-22.
1991: Nemunaitis J; Singer J W; Buckner C D; Mori T; Laponi J; Hill R; Storb R; Sullivan K M; Hansen J A; Appelbaum F R
Long-term follow-up of patients who received recombinant human granulocyte-macrophage colony stimulating factor after autologous bone marrow transplantation for lymphoid malignancy.
Bone marrow transplantation 1991;7(1):49-52.
1991: Buckner C D; Clift R A; Appelbaum F R; Storb R; Petersen F B; Sanders J E; Thomas E D; Hansen J A
Effects of treatment regimens in patients allografted for acute and chronic myelogenous leukemia.
Bone marrow transplantation 1991;7 Suppl 2():6-8.
1990: Clift R A; Buckner C D; Appelbaum F R; Bearman S I; Petersen F B; Fisher L D; Anasetti C; Beatty P; Bensinger W I; Doney K
Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens.
Blood 1990;76(9):1867-71.
1990: Sullivan K M; Kopecky K J; Jocom J; Fisher L; Buckner C D; Meyers J D; Counts G W; Bowden R A; Peterson F B; Witherspoon R P
Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation.
The New England journal of medicine 1990;323(11):705-12.
1990: Nemunaitis J; Singer J W; Buckner C D; Durnam D; Epstein C; Hill R; Storb R; Thomas E D; Appelbaum F R
Use of recombinant human granulocyte-macrophage colony-stimulating factor in graft failure after bone marrow transplantation.
Blood 1990;76(1):245-53.
1990: Storb R; Appelbaum F; Buckner C D; Clift R; Anasetti C; Beatty P; Bianco J; Doney K; Hansen J; Martin P
HLA-identical marrow transplantation in the leukemias without T-cell depletion. The Seattle Marrow Transplant Team.
Bone marrow transplantation 1990;6 Suppl 1():80-4.
1990: Storb R; Appelbaum F; Nemunaitis J; Schuening F; Singer J; Epstein C; Buckner C D; Souza L M; Thomas E D
Hematopoietic growth factors in marrow transplantation and radiation injury.
Bone marrow transplantation 1990;6 Suppl 1():116-20.
1990: Schubert M A; Sullivan K M; Schubert M M; Nims J; Hansen M; Sanders J E; O'Quigley J; Witherspoon R P; Buckner C D; Storb R
Gynecological abnormalities following allogeneic bone marrow transplantation.
Bone marrow transplantation 1990;5(6):425-30.
1990: Reusser P; Fisher L D; Buckner C D; Thomas E D; Meyers J D
Cytomegalovirus infection after autologous bone marrow transplantation: occurrence of cytomegalovirus disease and effect on engraftment.
Blood 1990;75(9):1888-94.
1990: Storb R; Buckner C D
Human bone marrow transplantation.
European journal of clinical investigation 1990;20(2):119-32.
1990: Bearman S I; Petersen F B; Schor R A; Denney J D; Fisher L D; Appelbaum F R; Buckner C D
Radionuclide ejection fractions in the evaluation of patients being considered for bone marrow transplantation: risk for cardiac toxicity.
Bone marrow transplantation 1990;5(3):173-7.
1990: Buckner C D
[The Antonio Raichs memorial lecture. Future trends in marrow transplantation]
Sangre 1990;35(1):60-3.
1990: Bensinger W I; Berenson R J; Andrews R G; Kalamasz D F; Hill R S; Bernstein I D; Lopez J G; Buckner C D; Thomas E D
Positive selection of hematopoietic progenitors from marrow and peripheral blood for transplantation.
Journal of clinical apheresis 1990;5(2):74-6.
1990: Appelbaum F R; Nemunaitis J; Singer J W; Buckner C D; Storb R; Thomas E D
Use of recombinant human granulocyte macrophage colony-stimulating factor to speed engraftment and treat graft failure following marrow transplantation in man.
Haematology and blood transfusion 1990;33():736-40.
1990: Storb R; Buckner C D; Clift R A; Appelbaum F R; Doney K C; Martin P; Anasetti C; Hansen J; Sanders J E; Petersen F B
Marrow grafting for acute leukemia: results and future treatment strategies.
Haematology and blood transfusion 1990;33():629-35.
1990: Berenson R J; Bensinger W I; Hill R; Andrews R G; Garcia-Lopez J; Kalamasz D F; Still B J; Buckner C D; Bernstein I D; Thomas E D
Stem cell selection--clinical experience.
Progress in clinical and biological research 1990;333():403-10; discussion 411-3.
1989: Petersen F B; Buckner C D; Appelbaum F R; Clift R A; Sanders J E; Bensinger W I; Storb R; Witherspoon R P; Sullivan K M; Bearman S I
Busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study.
Bone marrow transplantation 1989;4(6):617-23.
1989: Higuchi C M; Thompson J A; Cox T; Lindgren C G; Buckner C D; Fefer A
Lymphokine-activated killer function following autologous bone marrow transplantation for refractory hematological malignancies.
Cancer research 1989;49(20):5509-13.
1989: Petersen F B; Appelbaum F R; Bigelow C L; Buckner C D; Clift R A; Sanders J E; Storb R; Sullivan K M; Weiden P L; Fefer A
High-dose cytosine arabinoside, total body irradiation and marrow transplantation for advanced malignant lymphoma.
Bone marrow transplantation 1989;4(5):483-8.
1989: Bearman S I; Appelbaum F R; Back A; Petersen F B; Buckner C D; Sullivan K M; Schoch H G; Fisher L D; Thomas E D
Regimen-related toxicity and early posttransplant survival in patients undergoing marrow transplantation for lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(9):1288-94.
1989: Storb R; Deeg H J; Pepe M; Doney K; Appelbaum F; Beatty P; Bensinger W; Buckner C D; Clift R; Hansen J
Graft-versus-host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long-term follow-up of a controlled trial.
British journal of haematology 1989;72(4):567-72.
1989: Bensinger W; Petersen F B; Banaji M; Buckner C D; Clift R; Slichter S J; Storb R; Thomas E D
Engraftment and transfusion requirements after allogeneic marrow transplantation for patients with acute non-lymphocytic leukemia in first complete remission.
Bone marrow transplantation 1989;4(4):409-14.
1989: Storb R; Deeg H J; Pepe M; Appelbaum F; Anasetti C; Beatty P; Bensinger W; Berenson R; Buckner C D; Clift R
Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial.
Blood 1989;73(6):1729-34.
1989: Sullivan K M; Weiden P L; Storb R; Witherspoon R P; Fefer A; Fisher L; Buckner C D; Anasetti C; Appelbaum F R; Badger C
Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia.
Blood 1989;73(6):1720-8.
1989: Sullivan K M; Storb R; Buckner C D; Fefer A; Fisher L; Weiden P L; Witherspoon R P; Appelbaum F R; Banaji M; Hansen J
Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms.
The New England journal of medicine 1989;320(13):828-34.
1989: Beatty P G; Hansen J A; Anasetti C; Sanders J; Buckner C D; Storb R; Thomas E D
Marrow transplantation from unrelated HLA-matched volunteer donors.
Transplantation proceedings 1989;21(1 Pt 3):2993-4.
1989: Sullivan K M; Witherspoon R P; Storb R; Buckner C D; Sanders J; Thomas E D
Long-term results of allogeneic bone marrow transplantation.
Transplantation proceedings 1989;21(1 Pt 3):2926-8.
1989: Buckner C D; Sanders J; Appelbaum F R
Allogeneic marrow transplantation for acute non-lymphoblastic leukemia: first remission versus after first relapse.
Bone marrow transplantation 1989;4 Suppl 1():244-6.
1989: Hill R S; Mazza P; Amos D; Buckner C D; Appelbaum F R; Martin P; Still B J; Sica S; Berenson R; Bensinger W
Engraftment in 86 with patients lymphoid malignancy after autologous marrow transplantation.
Bone marrow transplantation 1989;4(1):69-74.
1989: Anasetti C; Amos D; Beatty P G; Appelbaum F R; Bensinger W; Buckner C D; Clift R; Doney K; Martin P J; Mickelson E
Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma.
The New England journal of medicine 1989;320(4):197-204.
1989: Mortimer J; Blinder M A; Schulman S; Appelbaum F R; Buckner C D; Clift R A; Sanders J E; Storb R; Thomas E D
Relapse of acute leukemia after marrow transplantation: natural history and results of subsequent therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(1):50-7.
1989: Buckner C D; Sanders J E; Anasetti C; Beatty P; Hansen J A; Storb R; Clift R; Thomas E D
Donors other than HLA-identical siblings.
Progress in clinical and biological research 1989;309():383-90.
1989: Sullivan K M; Buckner C D; Sanders J E; Anasetti C; Appelbaum F R; Clark J; Doney K; Meyers J; Sale G; Storb R
Long-term complications of bone marrow transplantation.
Progress in clinical and biological research 1989;309():367-74.
1989: Buckner C D; Sanders J E; Storb R
Bone marrow transplantation.
Progress in clinical and biological research 1989;309():317-23.
1988: Martin P J; Clift R A; Fisher L D; Buckner C D; Hansen J A; Appelbaum F R; Doney K C; Sullivan K M; Witherspoon R P; Storb R
HLA-identical marrow transplantation during accelerated-phase chronic myelogenous leukemia: analysis of survival and remission duration.
Blood 1988;72(6):1978-84.
1988: Petersen F B; Appelbaum F R; Buckner C D; Sanders J E; Clift R A; McGuffin R; Bearman S I; Flournoy N; Thomas E D
Simultaneous infusion of high-dose cytosine arabinoside with cyclophosphamide followed by total body irradiation and marrow infusion for the treatment of patients with advanced hematological malignancy.
Bone marrow transplantation 1988;3(6):619-24.
1988: Bearman S I; Appelbaum F R; Buckner C D; Petersen F B; Fisher L D; Clift R A; Thomas E D
Regimen-related toxicity in patients undergoing bone marrow transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(10):1562-8.
1988: Nemunaitis J; Singer J W; Buckner C D; Hill R; Storb R; Thomas E D; Appelbaum F R
Use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous marrow transplantation for lymphoid malignancies.
Blood 1988;72(2):834-6.
1988: Petersen F; Thornquist M; Buckner C; Counts G; Nelson N; Meyers J; Clift R; Thomas E
The effects of infection prevention regimens on early infectious complications in marrow transplant patients: a four arm randomized study.
Infection 1988;16(4):199-208.
1988: Sanders J E; Buckner C D; Amos D; Levy W; Appelbaum F R; Doney K; Storb R; Sullivan K M; Witherspoon R P; Thomas E D
Ovarian function following marrow transplantation for aplastic anemia or leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(5):813-8.
1988: Petersen F B; Sanders J E; Storb R; Bensinger W I; Clift R A; Buckner C D
Inadvertent administration of a greater-than-usual pre-marrow transplant dose of busulfan--report of a case.
Transplantation 1988;45(4):821-2.
1988: Riddell S; Appelbaum F R; Buckner C D; Stewart P; Clift R; Sanders J; Storb R; Sullivan K; Thomas E D
High-dose cytarabine and total body irradiation with or without cyclophosphamide as a preparative regimen for marrow transplantation for acute leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(4):576-82.
1988: Doney K; Storb R; Buckner C D; Thomas E D
Treatment of gold-induced aplastic anaemia with immunosuppressive therapy.
British journal of haematology 1988;68(4):469-72.
1988: Berenson R J; Andrews R G; Bensinger W I; Kalamasz D; Knitter G; Buckner C D; Bernstein I D
Antigen CD34+ marrow cells engraft lethally irradiated baboons.
The Journal of clinical investigation 1988;81(3):951-5.
1988: Storb R; Deeg H J; Fisher L; Appelbaum F; Buckner C D; Bensinger W; Clift R; Doney K; Irle C; McGuffin R
Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia: long-term follow-up of three controlled trials.
Blood 1988;71(2):293-8.
1988: Sanders J E; Buckner C D; Clift R A; Fefer A; McGuffin R; Storb R; Appelbaum F; Bensinger W; Beatty P; Doney K
Second marrow transplants in patients with leukemia who relapse after allogeneic marrow transplantation.
Bone marrow transplantation 1988;3(1):11-9.
1988: Sanders J E; Buckner C D; Sullivan K M; Doney K; Appelbaum F; Witherspoon R; Storb R; Thomas E D
Growth and development in children after bone marrow transplantation.
Hormone research 1988;30(2-3):92-7.
1987: Doney K; Buckner C D; Kopecky K J; Sanders J E; Appelbaum F R; Clift R; Sullivan K; Witherspoon R; Storb R; Thomas E D
Marrow transplantation for patients with acute lymphoblastic leukemia in first marrow remission.
Bone marrow transplantation 1987;2(4):355-63.
1987: Bensinger W I; Buckner C D; Clift R A; Williams B M; Banaji M; Thomas E D
Comparison of techniques for dealing with major ABO-incompatible marrow transplants.
Transplantation proceedings 1987;19(6):4605-8.
1987: Clift R A; Buckner C D; Thomas E D; Kopecky K J; Appelbaum F R; Tallman M; Storb R; Sanders J; Sullivan K; Banaji M
The treatment of acute non-lymphoblastic leukemia by allogeneic marrow transplantation.
Bone marrow transplantation 1987;2(3):243-58.
1987: Petersen F B; Buckner C D
Allogeneic and autologous bone marrow transplantation for acute leukemia and malignant lymphoma: current status.
Hematological oncology 1987;5(4):233-43.
1987: Petersen F B; Bowden R A; Thornquist M; Meyers J D; Buckner C D; Counts G W; Nelson N; Newton B A; Sullivan K M; McIver J
The effect of prophylactic intravenous immune globulin on the incidence of septicemia in marrow transplant recipients.
Bone marrow transplantation 1987;2(2):141-7.
1987: Sanders J; Buckner C D; Bensinger W I; Levy W; Chard R; Thomas E D
Experience with marrow harvesting from donors less than two years of age.
Bone marrow transplantation 1987;2(1):45-50.
1987: Dulley F L; Kanfer E J; Appelbaum F R; Amos D; Hill R S; Buckner C D; Shulman H M; McDonald G B; Thomas E D
Venocclusive disease of the liver after chemoradiotherapy and autologous bone marrow transplantation.
Transplantation 1987;43(6):870-3.
1987: Kanfer E J; Buckner C D; Fefer A; Storb R; Appelbaum F R; Hill R S; Amos D; Doney K C; Clift R A; Shulman H M
Allogeneic and syngeneic marrow transplantation following high dose dimethylbusulfan, cyclophosphamide and total body irradiation.
Bone marrow transplantation 1987;1(4):339-46.
1987: Doney K; Storb R; Buckner C D; McGuffin R; Witherspoon R; Deeg H J; Appelbaum F R; Sullivan K M; Thomas E D
Treatment of aplastic anemia with antithymocyte globulin, high-dose corticosteroids, and androgens.
Experimental hematology 1987;15(3):239-42.
1987: Kanfer E J; Petersen F B; Buckner C D; Stewart P; Storb R; Hill R S; Appelbaum F R; Clift R A; Doney K C; Shulman H M
Phase I study of high-dose dimethylbusulfan followed by autologous bone marrow transplantation in patients with advanced malignancy.
Cancer treatment reports 1987;71(1):101-2.
1987: Jin N R; Hill R; Segal G; Still B; Petersen F B; Amos D; Buckner C D; Clift R; Bensinger W; Martin P
Preparation of red-blood-cell-depleted marrow for ABO-incompatible marrow transplantation by density-gradient separation using the IBM 2991 blood cell processor.
Experimental hematology 1987;15(1):93-8.
1987: Williams B M; Sanders J E; Clift R A; Hickman R O; Bensinger W I; Buckner C D; Thomas E D
Use of arteriovenous shunts and right atrial catheters for daily granulocyte collection.
Journal of clinical apheresis 1987;3(3):171-3.
1987: Petersen F B; Buckner C D; Clift R A; Nelson N; Counts G W; Meyers J D; Thomas E D
Infectious complications in patients undergoing marrow transplantation: a prospective randomized study of the additional effect of decontamination and laminar air flow isolation among patients receiving prophylactic systemic antibiotics.
Scandinavian journal of infectious diseases 1987;19(5):559-67.
1987: Fefer A; Sullivan K M; Weiden P; Buckner C D; Schoch G; Storb R; Thomas E D
Graft versus leukemia effect in man: the relapse rate of acute leukemia is lower after allogeneic than after syngeneic marrow transplantation.
Progress in clinical and biological research 1987;244():401-8.
1987: Sullivan K M; Fefer A; Witherspoon R; Storb R; Buckner C D; Weiden P; Schoch G; Thomas E D
Graft-versus-leukemia in man: relationship of acute and chronic graft-versus-host disease to relapse of acute leukemia following allogeneic bone marrow transplantation.
Progress in clinical and biological research 1987;244():391-9.
1986: Deeg H J; Sullivan K M; Buckner C D; Storb R; Appelbaum F R; Clift R A; Doney K; Sanders J E; Witherspoon R P; Thomas E D
Marrow transplantation for acute nonlymphoblastic leukemia in first remission: toxicity and long-term follow-up of patients conditioned with single dose or fractionated total body irradiation.
Bone marrow transplantation 1986;1(2):151-7.
1986: Sanders J E; Pritchard S; Mahoney P; Amos D; Buckner C D; Witherspoon R P; Deeg H J; Doney K C; Sullivan K M; Appelbaum F R
Growth and development following marrow transplantation for leukemia.
Blood 1986;68(5):1129-35.
1986: Figuera A; Hill R S; Petersen F B; Still B J; Shilling D; Buckner C D
Controlled rate freezing of human marrow in a constant temperature cooling gradient in air.
Cryobiology 1986;23(5):470-5.
1986: Banaji M; Bearman S I; Buckner C D; Clift R A; Bensinger W I; Petersen F B; Slichter S J; McGuffin R W; Sanders J E; Stewart P S
The effects of splenectomy on engraftment and platelet transfusion requirements in patients with chronic myelogenous leukemia undergoing marrow transplantation.
American journal of hematology 1986;22(3):275-83.
1986: Petersen F B; Buckner C D; Clift R A; Lee S; Nelson N; Counts G W; Meyers J D; Sanders J E; Stewart P S; Bensinger W I
Laminar air flow isolation and decontamination: a prospective randomized study of the effects of prophylactic systemic antibiotics in bone marrow transplant patients.
Infection 1986;14(3):115-21.
1985: Jin N R; Hill R S; Petersen F B; Buckner C D; Stewart P S; Amos D; Appelbaum F R; Clift R A; Bensinger W I; Sanders J E
Marrow harvesting for autologous marrow transplantation.
Experimental hematology 1985;13(9):879-84.
1985: Storb R; Deeg H J; Thomas E D; Appelbaum F R; Buckner C D; Cheever M A; Clift R A; Doney K C; Flournoy N; Kennedy M S
Marrow transplantation for chronic myelocytic leukemia: a controlled trial of cyclosporine versus methotrexate for prophylaxis of graft-versus-host disease.
Blood 1985;66(3):698-702.
1985: Stewart P; Buckner C D; Bensinger W; Appelbaum F; Fefer A; Clift R; Storb R; Sanders J; Meyers J; Hill R
Autologous marrow transplantation in patients with acute nonlymphocytic leukemia in first remission.
Experimental hematology 1985;13(4):267-72.
1984: Schubert M M; Sullivan K M; Morton T H; Izutsu K T; Peterson D E; Flournoy N; Truelove E L; Sale G E; Buckner C D; Storb R
Oral manifestations of chronic graft-v-host disease.
Archives of internal medicine 1984;144(8):1591-5.
1984: Williams B M; Clift R A; Buckner C D; Hickman R O; Sanders J E; Stewart P S; Bensinger W I; Banaji M; Thomas E D
Granulocyte collection by continuous-flow centrifugation using arteriovenous shunts.
Journal of clinical apheresis 1984;2(2):206-9.
1983: Buckner C D; Clift R A; Thomas E D; Hersman J; Sanders J E; Stewart P S; Wade J C; Murphy M; Counts G; Meyers J D
Early infectious complications in allogeneic marrow transplant recipients with acute leukemia: effects of prophylactic measures.
Infection 1983;11(5):243-50.
1982: Thomas E D; Clift R A; Hersman J; Sanders J E; Stewart P; Buckner C D; Fefer A; McGuffin R; Smith J W; Storb R
Marrow transplantation for acute nonlymphoblastic leukemic in first remission using fractionated or single-dose irradiation.
International journal of radiation oncology, biology, physics 1982;8(5):817-21.
1982: Clift R A; Buckner C D; Thomas E D; Sanders J E; Stewart P S; McGuffin R; Hersman J; Sullivan K M; Sale G E; Storb R
Allogeneic marrow transplantation for acute lymphoblastic leukemia in remission using fractionated total body irradiation.
Leukemia research 1982;6(3):409-12.
1982: Clift R A; Buckner C D; Thomas E D; Sanders J E; Stewart P S; Sullivan K M; McGuffin R; Hersman J; Sale G E; Storb R
Allogeneic marrow transplantation using fractionated total body irradiation in patients with acute lymphoblastic leukemia in relapse.
Leukemia research 1982;6(3):401-7.
1981: Weiden P L; Zuckerman N; Hansen J A; Sale G E; Remlinger K; Beck T M; Buckner C D
Fatal graft-versus-host disease in a patient with lymphoblastic leukemia following normal granulocyte transfusion.
Blood 1981;57(2):328-32.

Sign-in to see more